Documenti di Didattica
Documenti di Professioni
Documenti di Cultura
Generic Name
Brand Name
Classification
Norepinephrine
Levophed
Vasopressor
Stimulates alpha adrenergic receptors located mainly in blood vessels, causing
constriction of both capacitance and resistance vessels
Action
Also has minor beta adrenergic activity (myocardial simulation)
Therapeutic Effects: Increased BP. Increased cardiac output.
IV (Adults): 0.5 1 mcg initially, followed by maintenance infusion of - 12
mcg/min titrated by BP response
Dosage
IV (Children): 0.1 mcg/kg/min initially, may be followed by infusion titrated o
BP response, up to 1 mcg/kg/min
Produces vasoconstriction and myocardial stimulation, which may be required after
Indication
adequate fluid replacement in the treatment of severe hypotension and shock.
Vascular, mesenteric or peripheral thrombosis, Hypoxia, Hypercabia, Hypotension
Contraindication secondary to hypovolemia (without appropriate volume replacement),
Hypersensitivity to bisulfites.
Use with cyclopropane or halothane anesthesia, cardiac glycosides, doxapram
or local use of cocaine may result in increased myocardial irritation ability
Use wit MAO inhibitors, methyldopa, doxapram or tricyclic antidepressants
may result in severe hypertension
Drug Interaction
Alpha- adrenergic blockers an prevent pressor response
Beta blockers my exaggerate hypertension or block cardiac stimulation
Concurrent use with ergot alkaloids (ergotamine, ergonovine, methylergonovine
or oxytocin) may result in enhanced vasoconstriction and hypertension
Anxiety, dizziness, headache, insomnia, restlessness, tremor, weakness
Dyspnea
Arrhythmias, bradycardia, chest pain hypertension
Side Effects and Decreased urine output, renal failure
Adverse Effects Hyperglycemia
Metabolic acidosis
Phlebitis at IV site
Fever
Nursing
Responsibilities